Why post-traumatic knee injuries often need OCA

A serious knee injury — an intra-articular fracture, a high-energy impact, a collision that splits the joint surface — can leave behind damage that no injection or minor procedure will adequately address. The question many patients reach is a practical one: is there anything between living with a damaged knee and having it replaced entirely? For the right candidate, fresh osteochondral allograft (OCA) transplantation is that option.

Cartilage repair follows a rough ladder. Minor, superficial lesions under 2 cm² may respond to an osteochondral autograft (OATS) taken from a low-load area of the patient's own knee, or to injectable scaffold treatments such as ChondroFiller injection for suitable focal defects. Larger chondral-only defects in the 2–4 cm² range, without significant bone loss, may suit a cell-based approach such as MACI. But trauma changes the picture. Intra-articular fractures and high-energy impacts routinely produce defects that are large (commonly well above 2–4 cm²), full-thickness, and — critically — extend into the subchondral bone: the structural layer of bone immediately beneath the cartilage surface that gives the joint its mechanical foundation. When that bone layer is damaged or lost, purely chondral techniques cannot restore the joint's architecture in a single step.

OCA addresses this by transplanting a precisely matched plug of donor cartilage together with its underlying bone, replacing both layers at once. Since October 2022, NHS England has routinely commissioned OCA as a Group D specialised service for eligible adults and post-pubescent children, meaning Lincolnshire patients can access it through NHS specialist commissioning without an individual funding request.

Who is a suitable candidate

Three questions guide whether OCA is worth exploring: what the damage looks like structurally, what the patient's overall health picture shows, and whether the joint's mechanics can support a graft long-term. No patient can answer these definitively without imaging and clinical examination, but understanding each axis helps frame what a consultation will assess.

The defect needs to be focal and contained — affecting one surface only (unipolar), not both opposing surfaces simultaneously. A kissing lesion, where cartilage loss faces cartilage loss across the joint, substantially reduces graft success. The damage should be full-thickness (Outerbridge Grade III–IV), typically larger than 2 cm², and extend into the subchondral bone layer rather than the cartilage surface alone. Unicompartmental location — medial condyle, lateral condyle, or trochlea — forms part of the structural assessment.

The patient profile matters as much as the defect. OCA works best in those who are physically active and, ideally, under 50. Age is the single strongest modifiable predictor of graft survival: younger patients consistently show better long-term outcomes across published cohorts, though age alone is not an absolute cut-off. Generalised osteoarthritis (Kellgren-Lawrence grade 3 or above), inflammatory arthritis such as rheumatoid arthritis, and advanced multi-compartmental disease are exclusions — those presentations are more appropriately addressed in a joint-preservation or replacement discussion.

Joint mechanics form the third axis. The menisci need to be intact or restorable, and ligamentous stability — including the ACL — must be confirmed or surgically addressed before or during the procedure. Limb alignment is perhaps the most critical mechanical consideration: uncorrected varus or valgus deformity concentrates load directly onto the graft and is among the strongest predictors of early failure. Where alignment is off, a high tibial osteotomy (HTO) or distal femoral osteotomy (DFO) is typically planned as part of the same operative episode rather than deferred — published series report that up to 46% of OCA patients require a concurrent load-redistribution procedure.

Under NHS England commissioning criteria, an additional gateway applies: documented prior failure of, or unsuitability for, other cartilage interventions. For post-traumatic defects involving subchondral bone loss, however, OCA frequently qualifies as the primary reconstruction rather than a salvage fallback.

The graft freshness constraint and what it means for patients

Unlike most elective orthopaedic procedures, OCA cannot simply be booked and scheduled within a standard waiting list cycle. The biology of the graft sets the timetable: donor cartilage must be implanted within 28–35 days of harvest, without exposure to radiation or prolonged freezing. Frozen or irradiated alternatives do not preserve living chondrocytes, and it is the viability of those cells — ideally ≥70% at the time of implantation — that underpins successful integration. This is what makes OCA categorically different from other allograft techniques.

Coordinating that window means matching donor joint dimensions precisely to the recipient's knee, confirming tissue availability, and aligning surgical teams — logistics that are concentrated in specialist centres with dedicated procurement pathways. For Lincolnshire patients, this typically means referral to a regional or national specialist unit for the procedure itself. That is a normal feature of how NHS England commissions OCA as a Group D specialised service, not an obstacle specific to this region. Patients can ask their referring team which centre covers their area and what the current coordination pathway looks like.

Where concomitant procedures are planned — a high tibial osteotomy, ACL reconstruction, or meniscal allograft — these need to be scoped and timed in advance. The additional surgical planning adds complexity to the pre-operative pathway but does not, in published series, worsen graft outcomes when the joint is prepared and aligned correctly before or during the same operative episode.

Long-term graft survival and functional outcomes

The survivorship data for OCA is among the most mature of any cartilage repair technique, drawn from cohorts followed for two decades or more. At five years, approximately 87% of grafts remain functional; at ten years that figure sits around 79%. The Haikal et al. 2023 systematic review records 72.8% at fifteen years and 67.5% at twenty years; the NHS England evidence review documents a wider range of 64–84% at fifteen years and 47–69% at twenty years. That spread reflects genuine differences in patient mix across the contributing cohorts — age, defect size, lesion aetiology, and concurrent procedures all vary between series — rather than noise in the data itself.

One methodological limitation applies throughout: all available evidence comes from observational cohorts. No randomised controlled trial has directly compared OCA with MACI or ACI for post-traumatic defects specifically, so precise head-to-head figures are not available. The cohort data are, however, extensive and long-running.

Functional recovery benchmarks are more encouraging than the raw survival curve suggests. At a mean six-year follow-up, 75% of patients — 112 of 149 knees in one series — had returned to sport or recreational activity; 71% rated their knee function as very good to excellent on IKDC subjective evaluation, and 79% reached a high activity level on the same score.

Outcomes are consistently better in patients under 40 with isolated unipolar lesions and corrected limb alignment — the profile most likely to emerge from a post-traumatic presentation in an otherwise healthy, active adult. In a separate cohort, 68% of grafts remained in situ and functioning at a mean of 12.9 years, giving younger patients a realistic window before joint replacement becomes relevant.

Failure, reoperation, and the path to knee replacement

Roughly 15–18% of OCA grafts ultimately fail — a figure worth putting into context before it causes unnecessary alarm. The primary drivers are patient age above 50 at implantation, bipolar (kissing) lesions where both sides of the joint are involved, and limb malalignment that was not corrected at the time of surgery. These are, largely, factors that careful patient selection and pre-operative planning address rather than unpredictable biological events. The graft itself carries minimal immunological risk; bone is immunologically privileged due to low cellularity, and rejection in the conventional sense is not the dominant failure mechanism.

The lifetime reoperation figure — 36–43% — sounds higher than it is. The majority of these interventions are minor arthroscopic procedures: removal of loose bodies, debridement, or hardware removal. Full graft excision or conversion to arthroplasty accounts for a much smaller proportion.

Critically, when OCA does fail, it typically does so after a decade or more of useful function. For a patient in their 20s or 30s at the time of surgery, that interval is clinically meaningful: it allows them to reach an age at which total knee replacement carries better implant longevity and a more appropriate surgical risk profile. OCA is not a guarantee — but it is not a dead end either. A failed graft that has provided ten to fifteen years of activity before eventual joint replacement represents a planned progression, not a treatment failure.

Getting assessed and accessing OCA in Lincolnshire

Navigating the route to OCA involves two distinct steps: confirming eligibility, and then accessing the procedure through the appropriate specialist pathway.

Eligible adults and post-pubescent children do not need an individual funding request to access OCA on the NHS — it is routinely commissioned for qualifying patients, as covered earlier in this article. Referral moves through NHS specialist commissioning channels, and the procedure itself is performed at a specialist orthopaedic centre. For most Lincolnshire patients, that means a regional or national unit rather than a local hospital. This is expected for a technically demanding procedure that requires precise donor matching and coordinated timing, not a cause for concern.

Pre-operative assessment is thorough by design. It typically covers MRI to map cartilage defect depth and subchondral bone integrity, weight-bearing X-rays to quantify limb alignment, and a full biomechanical evaluation to identify concurrent problems — malalignment, ligament instability, or meniscal deficiency — that would need to be addressed at the same time as the graft.

For patients in Lincolnshire looking for a clear starting point, Lincolnshire Knee offers consultant-led knee assessment at Sleaford NG34 and Grantham NG31 without the need for a GP referral. The focus is candidacy evaluation: establishing whether OCA is the right pathway and assembling the clinical picture needed for onward specialist referral. Where relevant, onMRI™ AI-driven cartilage analysis and MAI Motion® objective biomechanical assessment can contribute to that pre-operative workup.

Lincolnshire Knee is part of the MSK Doctors group and accepts patients without referral. Book an assessment at lincolnshireknee.co.uk.